India’s health and pharma sectors are optimistic ahead of the February 1, 2026, Union Budget. With days to go, demands for increased public funding, GST rationalization, digital advancements, and research boosts are intensifying. This could be the catalyst for a stronger, more equitable health framework.
Experts insist on scaling health spend to 3-5% GDP, as NCDs claim 65% lives against meager current outlays. A resilient system hinges on this uplift.
At this pivotal moment, one analyst urged surpassing 2.5% GDP spending to nurture a sustainable health ecosystem for generations.
The 2025 GST slash to 5% on devices was a start, but inverted structures—like 18% on radiation protectors—must align to 5%, aiding manufacturers and affordability.
Breaking 80% import reliance requires empowering ‘Buy India’ with fortified PRIP-like R&D programs for superior local devices.
Prioritizing Tier-2/3 and rural health via PSL, VGF for hubs and eye hospitals ensures widespread access to quality services.
AI, IoT, and digital platforms promise early detection and preventive shifts, enhancing efficiency and outcomes dramatically.
Integration of digital infra with diagnostics, pharmacies, and home care, plus healthtech incentives, will redefine patient care standards.
The verdict is clear: Budget 2026 must deliver real impact through spending surges, policy reforms, digital innovation, and self-reliance, paving way for a world-class health system.